Estrone Estrogen/progestogen Receptor chemical

Cat.No.S1665

Estrone is an estrogenic hormone.
Estrone Estrogen/progestogen Receptor chemical Chemical Structure

Chemical Structure

Molecular Weight: 270.37

Jump to

Quality Control

Batch: Purity: 99.97%
99.97

Solubility

In vitro
Batch:

DMSO : 54 mg/mL (199.72 mM)
(Moisture-contaminated DMSO may reduce solubility. Use fresh, anhydrous DMSO.)

Water : Insoluble

Ethanol : Insoluble

Molarity Calculator

Mass Concentration Volume Molecular Weight
Dilution Calculator Molecular Weight Calculator

In vivo
Batch:

In vivo Formulation Calculator (Clear solution)

Step 1: Enter information below (Recommended: An additional animal making an allowance for loss during the experiment)

mg/kg
g
μL

Step 2: Enter the in vivo formulation (This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)

% DMSO
%
% Tween 80
% ddH2O
% DMSO
+
%

Calculation results:

Working concentration: mg/ml;

Method for preparing DMSO master liquid: mg drug pre-dissolved in μL DMSO ( Master liquid concentration mg/mL, Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug. )

Method for preparing in vivo formulation: Take μL DMSO master liquid, next addμL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O, mix and clarify.

Method for preparing in vivo formulation: Take μL DMSO master liquid, next add μL Corn oil, mix and clarify.

Note: 1. Please make sure the liquid is clear before adding the next solvent.
2. Be sure to add the solvent(s) in order. You must ensure that the solution obtained, in the previous addition, is a clear solution before proceeding to add the next solvent. Physical methods such
as vortex, ultrasound or hot water bath can be used to aid dissolving.

Chemical Information, Storage & Stability

Molecular Weight 270.37 Formula

C18H22O2

Storage (From the date of receipt)
CAS No. 53-16-7 Download SDF Storage of Stock Solutions

Synonyms N/A Smiles CC12CCC3C(C1CCC2=O)CCC4=C3C=CC(=C4)O

Mechanism of Action

Targets/IC50/Ki
estrogen receptor

Clinical Trial Information

(data from https://clinicaltrials.gov, updated on 2024-05-22)

NCT Number Recruitment Conditions Sponsor/Collaborators Start Date Phases
NCT05900895 Not yet recruiting
Metastatic Breast Cancer
Mary D Chamberlin|Dartmouth-Hitchcock Medical Center
May 2024 Phase 1
NCT06136208 Recruiting
Climacteric Syndrome|Menopause|Hypoestrogenism
Science Valley Research Institute|Biòs Farmacêutica
December 13 2023 Not Applicable
NCT05974449 Recruiting
Breast Cancer Female
The First Affiliated Hospital with Nanjing Medical University
August 24 2023 Phase 2
NCT05967819 Recruiting
Amenorrhea Secondary
University of Colorado Colorado Springs
August 9 2023 Not Applicable
NCT05607004 Recruiting
Breast Neoplasms|Invasive Breast Cancer|Estrogen-receptor-positive Breast Cancer|HER2-negative Breast Cancer
Atossa Therapeutics Inc.|InClin
February 14 2023 Phase 2

Tech Support

Handling Instructions

Tel: +1-832-582-8158 Ext:3

If you have any other enquiries, please leave a message.

Signaling Pathway Map